Mark A. Wan, Director, 10% Owner at ACELRX PHARMACEUTICALS INC (ACRX), sold 1,000,000 shares at $12.39 ($12.4M) on 2014-03-07, disclosed to the SEC on 2014-03-11.
Open-market sale of $12.4M ACRX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.96 | 12,186 | $146K | 1.2% |
| 2 | $11.96 | 20,800 | $249K | 2.0% |
| 3 | $11.96 | 459 | $5K | 0.0% |
| 4 | $11.96 | 655 | $8K | 0.1% |
| 5 | $12.39 | 46,661 | $578K | 4.7% |
| 6 | $12.39 | 1,759 |
| $22K |
| 0.2% |
| 7 | $12.39 | 2,508 | $31K | 0.3% |
| 8 | $12.39 | 79,645 | $987K | 8.0% |
| 9 | $12.36 | 11,250 | $139K | 1.1% |
| 10 | $12.36 | 16,049 | $198K | 1.6% |
| 11 | $12.36 | 298,508 | $3.7M | 29.9% |
| 12 | $12.36 | 509,520 | $6.3M | 51.0% |
| Total | $12.35 avg | 1,000,000 | $12.4M | 100% |
| Filing → |
| EPOC | SELL | 2011-02-07 | $4.7M | — | Filing → |